Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2014 | Research article

Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache: meta-analysis of four randomized, double-blind, placebo-controlled, crossover studies

Authors: Hans-Christoph Diener, Morris Gold, Martina Hagen

Published in: The Journal of Headache and Pain | Issue 1/2014

Abstract

Background

Most patients with episodic tension-type headache treat headache episodes with over-the-counter medication. Combination analgesics containing caffeine may be more effective and as well tolerated as monotherapy. The aim of this study was to evaluate the efficacy of the combination of acetylsalicylic acid, acetaminophen (paracetamol) and caffeine in episodic tension-type headache using recently recommended endpoints.

Methods

Four randomized, controlled trials of identical design in 1,900 patients with episodic tension-type headache comparing acetylsalicylic acid, acetaminophen and caffeine vs. acetaminophen or placebo were pooled. Analysis populations were ‘all headache episodes’ and those with ‘severe pain at baseline’. Post-hoc defined primary endpoint: headache episodes pain-free at 2 h. Secondary endpoints: headache episodes pain-free at 1 h, headache response at 2 h (mild or no pain), degree of interference with daily activities.

Results

6,861 headache episodes were treated, including 2,215 severe headache episodes. The proportion of headache episodes pain-free at 2 h was significantly higher with the triple combination (28.5%) vs. acetaminophen (21.0%) and placebo (18.0%) (p < 0.0001), and similarly for those severe at baseline (20.2% vs. 12.1% and 10.8%; p ≤ 0.0003). A similar pattern of superiority was observed for secondary endpoints. The triple combination was generally well tolerated.

Conclusions

The combination of acetylsalicylic acid, acetaminophen and caffeine is effective and well tolerated in episodic tension-type headache, and significantly superior to acetaminophen with regard to being pain-free at 2 h, headache response at 2 h and ability to return to daily activities, even in those with pain rated severe at baseline.

Available only for authorised users

Sahler K: Epidemiology and cultural differences in tension-type headache. Curr Pain Headache Rep 2012, 16: 525–532. 10.1007/s11916-012-0296-5CrossRefPubMed

Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27(3):193–210. 10.1111/j.1468-2982.2007.01288.xCrossRefPubMed

Rasmussen B, Jensen R, Olesen J: Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992, 46: 443–446. 10.1136/jech.46.4.443PubMedCentralCrossRefPubMed

Pfaffenrath V, Diener H, Pageler L, Peil H, Aicher B: OTC analgesics in headache treatment: open-label phase vs randomized double-blind phase of a large clinical trial. Headache 2009, 49: 638–645. 10.1111/j.1526-4610.2009.01402.xCrossRefPubMed

Brennum J, Brinck T, Schriver L, Wanscher B, Soelberg Sorensen P, Tfelt-Hansen P, Olesen J: Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol 1996, 3: 23–28. 10.1111/j.1468-1331.1996.tb00184.xCrossRef

Scher A, Lipton R, Stewart W, Bigal M: Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 2010, 30(3):321–328.PubMed

Bendtsen L, Evers S, Linde M, Mitsikostas D, Sandrini G, Schoenen J: EFNS guideline on the treatment of tension-type headache - Report of an EFNS task force. Eur J Neurol 2010, 17: 1318–1325.PubMed

Straube A, Aicher B, Fiebich B, Haag G: Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics? BMC Neurol 2011, 11(43):1–15.

Diener H, Pfaffenrath V, Pageler L, Peil H, Aicher B: The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 2005, 25: 776–787. 10.1111/j.1468-2982.2005.00948.xCrossRefPubMed

10.

Migliardi J, Armellino J, Friedman M, Gillings D, Beaver W: Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994, 56(5):576–586. 10.1038/clpt.1994.179CrossRefPubMed

11.

Silberstein S, Newman L, Marmura M, Nahas S, Farr S: Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain. Curr Med Res Opin 2013, 29(7):861–867. 10.1185/03007995.2013.787980CrossRefPubMed

12.

Bendtsen L, Bigal M, Cerbo R, Diener H, Holroyd K, Lampl C, Mitsikostas D, Steiner T, Tfelt-Hansen P: Guidelines for controlled trials of drugs in tension-type headache: second edition. Cephalalgia 2010, 30(1):1–16.PubMed

13.

Ad Hoc Committee on Classification of Headache: Classification of headache. JAMA 1962, 179(9):717–718.CrossRef

14.

Headache Classification Committee of the International Headache Society (IHS): The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013, 33(9):629–808.CrossRef

15.

Bosse K, Kuhner A: Treatment of headache of different genesis - results of a double-blind multicenter study [in German]. Therapiewoche 1988, 38: 3879–3884.

16.

Pini L, Del Bene E, Zanchin G, Sarchielli P, Di Trapani G, Prudenzano M, LaPegna G, Savi L, Di Loreto G, Dionisio P, Granella F: Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium. J Headache Pain 2008, 9: 367–373. 10.1007/s10194-008-0071-5PubMedCentralCrossRefPubMed

17.

Laska E, Sunshine A, Mueller F, Elvers W, Siegel C, Rubin A: Caffeine as an analgesic adjuvant. JAMA 1984, 251(13):1711–1718. 10.1001/jama.1984.03340370043028CrossRefPubMed

18.

Haag G, Diener H, May A, Meyer C, Morck H, Straube A, Wessely P, Evers S: Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migraine und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft fur Neurologie (DGN), the Osterreichische Kopfschmerzgesellschaft (OKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 2011, 12: 201–217. 10.1007/s10194-010-0266-4PubMedCentralCrossRefPubMed

19.

Sarchielli P, Granella F, Prudenzano M, Pini L, Guidetti V, Bono G, Pinessi L, Alessandri M, Antonaci F, Fanciullaci M, Ferrari A, Guazzelli M, Nappi G, Sances G, Sandrini G, Savi L, Tassorelli C, Zanchin G: Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 2012, 13(Suppl 2):S31-S70.CrossRefPubMed

20.

Rasmussen B, Jensen R, Olesen J: A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991, 11: 129–134. 10.1046/j.1468-2982.1991.1103129.xCrossRefPubMed

21.

Kubitzek F, Ziegler G, Gold M, Liu JM, Ionescu E: Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003, 7: 155–162. 10.1016/S1090-3801(02)00094-0CrossRefPubMed

22.

Diamond S, Freitag F: The use of ibuprofen plus caffeine to treat tension-type headache. Curr Pain Headache Rep 2001, 5: 472–478. 10.1007/s11916-001-0060-8CrossRefPubMed

23.

Diener H, Pfaffenrath V, Pageler L, Peil B, Aicher B, Lipton R: Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics. Cephalalgia 2009, 29(2):188–193. 10.1111/j.1468-2982.2008.01706.xCrossRefPubMed

24.

Moore D, Keogh E, Eccleston C: Headache impairs attentional performance. Pain 2013, 154: 1840–1845. 10.1016/j.pain.2013.06.006CrossRefPubMed

25.

Schwartz BS, Stewart WF, Lipton RB: Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997, 39: 320–327. 10.1097/00043764-199704000-00009CrossRefPubMed

26.

Linde M, Gustavsson A, Stovner L, Steiner T, Barre J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz De La Torre E, Tassorelli C, Andrée C: The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 2012, 19(5):703–711. 10.1111/j.1468-1331.2011.03612.xCrossRefPubMed

27.

Jones B, Kenward M (Eds): Design and Analysis of Crossover Trials. London: Chapman & Hall; 1989.

Title: Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache: meta-analysis of four randomized, double-blind, placebo-controlled, crossover studies
Authors: Hans-Christoph Diener
Morris Gold
Martina Hagen
Publication date: 01-12-2014
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/1129-2377-15-76

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache: meta-analysis of four randomized, double-blind, placebo-controlled, crossover studies

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation

Gender differences of cognitive function in migraine patients: evidence from event-related potentials using the oddball paradigm

A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome

The serotonin transporter gene polymorphism is associated with the susceptibility and the pain severity in Idiopathic Trigeminal Neuralgia patients

A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based?